Trump has unveiled a number of moves aimed at cutting drug prices in recent months, but he has yet to move the needle on ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

President Trump said Monday his administration is “looking at” reclassifying marijuana as a less dangerous drug. Such a move would continue efforts begun by the Biden administration, which started the ...

The Wasatch Global Select Fund—Investor Class gained 11.87%, and slightly outperformed the benchmark MSCI AC (All Country) ...

WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.

Mordor Intelligence recently released comprehensive reports on compounding pharmacy market and pharma manufacturing industry, ...

Plus more pharma news from the Pharmalittle newsletter.

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...

European supplement manufacturing is booming but finding manufacturers who actually deliver quality products consistently is ...

Some of Philadelphia’s biotechnology companies that specialize in cell therapy shed employees in recent weeks as the industry is facing some unique headwinds.

But the company would have to stall the profit drag from declines in volume for happoshu and new genre. Kirin’s strength in ready-to-drink spirits could help offset the decline in beer volumes. Kirin ...